BARDA

BARDA

Biodefense Headlines – 31 March 2025

Biosecurity March 31, 2025

This week’s topics include restructuring of ASPR, anti-vaccine leadership at NIH, the UK’s new pathogen priority research targets list, and data on a post-exposure treatment for filoviruses. FEATURED Trump Administration…

BARDA Backs Antibody Therapy Against MERS Virus

HHS Funds Rapid, High-Capacity Zika Serological Diagnostic

HHS Backs Hologic’s Zika Blood Screening Test

HHS Summit to Accelerate Zika Diagnostics Development

Superbugs & Superdrugs Comes to the U.S.

Burn Treatment Gets Additional Backing from BARDA

Anthrax Capsule Vaccine Shows Promise

CIADM to Accelerate Zika Vaccine Development

Emergent Passes Inspection of Anthrax Vaccine Manufacturing Facility

BARDA Backs Cerus’ Blood Pathogen Reduction System

BARDA and the Battle Against MCR-1

UVA Researchers Identify Potential Countermeasures for Radiation Exposure

Fishing for Phages to Treat Dangerous Infections

BARDA Seeks Next-Generation Anthrax Vaccine

Study: The Importance of Disrobing in Chemical Decontamination

BARDA Awards 2.5M Contract to Advance Anthrax Diagnostic

NIAID’s Pre-Clinical Models of Infectious Diseases Program

Anthrax Infections and DoD Anthrax Vaccine Policy

HHS Helping Lift Key Hurdle in Zika Diagnostics Development

BARDA Awards Contract to Basilea for Broad-Spectrum Antibiotic

Biodefense Headlines – 31 March 2025